v3.25.2
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:    
Net loss $ (2,552,651) $ (6,394,295)
Adjustments to reconcile net loss to net cash used in operating activities:    
Amortization and depreciation 508,135 1,361,628
Common stock and stock option based compensation for employees and board of directors 984,143 2,175,072
Net gain on divestiture of subsidiaries (1,392,434) (1,000,000)
Reserve on notes received in connection with divestiture of subsidiaries 1,500,000 1,000,000
Gain on office lease termination (34,660)
Accrued non cash performance bonus fair value adjustment (551,239)
Acquisition contingent consideration fair value adjustment 102,412 (4,272,080)
Impairment of intangible assets 2,942,369
Issuance of common stock to vendors 4,601 100,372
Adjustment to operating lease right-of-use assets and liabilities (46,062) (110,866)
Changes in operating assets and liabilities:    
Accounts receivable (117,519) 730,738
Deferred costs 121,810 (12,229)
Prepaid expenses and other current assets 488,371 (216,018)
Other assets 5,349 (948)
Accounts payable 46,703 (274,109)
Accrued liabilities 109,062 (294,637)
Deferred revenue (1,034) (393,605)
Net cash used in operating activities (273,774) (5,209,847)
Cash flow from investing activities:    
Purchase of leasehold improvements and equipment (42,508) (31,548)
Payment of contingent consideration for acquisition (1,500,000) (1,497,894)
Cash used in investing activities (1,542,508) (1,529,442)
Cash flows provided by financing activities:    
Proceeds from securities purchase agreement, net 6,785,552 2,968,501
Proceeds from exercise of warrants 175,760
Issuance of notes receivable (189,000)
Notes receivable repayments 28,400
Net cash provided by financing activities 6,800,712 2,968,501
Net change in cash and cash equivalents 4,984,430 (3,770,788)
Cash and cash equivalents, beginning of year 1,848,295 5,619,083
Cash and cash equivalents, end of year 6,832,725 1,848,295
Non-cash Investing and Financing activities:    
Issuance of common stock for satisfaction of contingent liability 974,646
Issuance of common stock for non cash performance bonus 490,357
Lease liabilities arising from right-of-use assets $ 20,344